Forums – mark1101 – Melanoma Research Foundation

Forum Topics Started

Viewing 15 topics - 1 through 15 (of 15 total)

- TOPIC
- Zelboraf side effects
  Started by: mark1101 General Melanoma Community
- 3
- 9
- Richard_K
  
  11 years, 8 months ago
- Starting IL-2 treatment soon
  Started by: mark1101 General Melanoma Community
- 8
- 42
- Kim K
  
  11 years, 8 months ago
- Bone mets and vemurafenib
  Started by: mark1101 General Melanoma Community
- 2
- 6
- Bubbles
  
  11 years, 10 months ago
- HD IL-2 and Zelboraf trial
  Started by: mark1101 General Melanoma Community
- 4
- 18
- Bubbles
  
  11 years, 11 months ago
- Disconcerting news today
  Started by: mark1101 General Melanoma Community
- 6
- 27
- mark1101
  
  11 years, 11 months ago
- BRAF Positive
  Started by: mark1101 General Melanoma Community
- 4
- 33
- Bubbles
  
  11 years, 11 months ago
- New met on iliac
  Started by: mark1101 General Melanoma Community
- 3
- 12
- mark1101
  
  12 years ago
- Ipi and itching/rash
  Started by: mark1101 General Melanoma Community
- 4
- 21
- mark1101
  
  12 years, 2 months ago
- Prednisone “withdrawal”
  Started by: mark1101 General Melanoma Community
- 5
- 21
- NYKaren
  
  12 years, 4 months ago
- Squamous cell carcinoma
  Started by: mark1101 Cutaneous Melanoma Community
- 2
- 6
- Tim–MRF
  
  12 years, 4 months ago
- Itch and rash reaction with Ipi
  Started by: mark1101 General Melanoma Community
- 4
- 18
- mark1101
  
  12 years, 4 months ago
- Finished my last infusion of ipilimumab
  Started by: mark1101 General Melanoma Community
- 1
- 3
- tasjacques
  
  12 years, 7 months ago
- Shingles Vaccine
  Started by: mark1101 General Melanoma Community
- 7
- 24
- lou2
  
  12 years, 8 months ago
- Melanoma and sun exposure
  Started by: mark1101 General Melanoma Community
- 3
- 9
- Linny
  
  12 years, 8 months ago
- Just starting Ipilimumab Clinical Trial for Stage III
  Started by: mark1101 General Melanoma Community
- 3
- 15
- mel123
  
  12 years, 9 months ago

Viewing 15 topics - 1 through 15 (of 15 total)